IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $129,000 | +55.4% | 4,661 | +2.2% | 0.00% | 0.0% |
| Q3 2019 | $83,000 | -25.2% | 4,561 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $111,000 | +42.3% | 4,561 | -43.8% | 0.00% | 0.0% |
| Q1 2019 | $78,000 | +8.3% | 8,118 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $72,000 | +24.1% | 8,118 | +58.6% | 0.00% | 0.0% |
| Q3 2018 | $58,000 | -47.7% | 5,118 | -41.1% | 0.00% | -50.0% |
| Q2 2018 | $111,000 | -53.6% | 8,696 | -38.6% | 0.00% | -33.3% |
| Q1 2018 | $239,000 | +1095.0% | 14,169 | +455.6% | 0.00% | – |
| Q4 2017 | $20,000 | -13.0% | 2,550 | -15.0% | 0.00% | – |
| Q3 2017 | $23,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |